ADJUVANT IMMUNOTHERAPY FOR VULVAR MALIGNANT MELANOMAWALLACH RC; TAUB RN.1979; MOUNT SINAI J. MED.; USA; DA. 1979; VOL. 46; NO 2; PP. 161-162; BIBL. 20 REF.Article

FAMILIAL BENIGN CYSTIC TERATOMATABRENNER SH; WALLACH RC.1983; INTERNATIONAL JOURNAL OF GYNAECOLOGY AND OBSTETRICS; ISSN 0020-7292; USA; DA. 1983; VOL. 21; NO 2; PP. 167-169; BIBL. 14 REF.Article

MEIOTIC CHROMOSOMAL CHANGES IN STERILITY PRODUCED BY NITROGEN MUSTARD AND PROCARBAZINE IN MICECHRYSSANTHOU CP; WALLACH RC; ATCHISON M et al.1983; FERTILITY AND STERILITY; ISSN 0015-0282; USA; DA. 1983; VOL. 39; NO 1; PP. 97-102; BIBL. 20 REF.Article

EVOLUTION OF FUNCTIONAL OVARIAN CYSTS: SONOGRAPHIC APPEARANCE AND MANAGEMENTTURETZ F; SMULEWICZ J; WALLACH RC et al.1979; INTERNATION. J. GYNEACOL. OBSTETR.; USA; DA. 1979-1980; VOL. 17; NO 4; PP. 312-322; BIBL. 9 REF.Article

COMPARISON OF PREGNANCIES AND BIRTHS DURING METHADONE DETOXIFICATION AND MAINTENANCEWALLACH RC; JEREZ E; BLINICK G et al.1975; PEDIATR. ANN.; U.S.A.; DA. 1975; VOL. 4; NO 7; PP. 46-61 (9P.); BIBL. 35 REF.Article

INTRAVENOUS CHEMOTHERAPY WITH CONCURRENT PERITONEAL DIALYSIS: CONTINUED TREATMENT OF OVARIAN CARCINOMA AFTER DRUG TOXICITY.WALLACH RC; KABAKOW B; BLINICK G et al.1976; GYNECOL. ONCOL.; U.S.A.; DA. 1976; VOL. 4; NO 3; PP. 299-306; BIBL. 12 REF.Article

AMNIOTIC FLUID METHADONE IN WOMEN MAINTAINED ON METHADONE = METHADONE AMNIOTIQUE CHEZ LES FEMMES SOUS METHADONEBLINICK G; INTURRISI CE; JEREZ E et al.1974; MOUNT SINAI J. MED.; U.S.A.; DA. 1974; VOL. 41; NO 2; PP. 254-259; BIBL. 14REF.Article

MANAGEMENT OF OVARIAN CARCINOMA: A REVIEW OF 14 YEARS' EXPERIENCE AT BETH ISRAEL HOSPITAL = TRAITEMENT DU CANCER DE L'OVAIRE: BILAN DE 14 ANS D'EXPERIENCE A L'HOPITAL DE BETH ISRAELBLINICK G; KABAKOW B; ANTOPOL W et al.1972; MOUNT SINAI J. MED.; U.S.A.; DA. 1972; VOL. 39; NO 5; PP. 447-457; BIBL. 1P.1/2Article

PRENATAL DETECTION OF PERICENTRIC INVERSION OF CHROMOSOME 12KIM HJ; IU B; LEVY J et al.1980; DIAGN. GYNECOL. OBSTET.; USA; DA. 1980; VOL. 2; NO 3; PP. 231-234; BIBL. 8 REF.Article

TREATMENT OF ADVANCED OVARIAN CANCER WITH CIS-DICHLORODIAMMINEPLATINUM (II): POOR-RISK PATIENTS WITH INTENSIVE PRIOR THERAPY.BRUCKNER HW; COHEN CJ; WALLACH RC et al.1978; CANCER TREATM. REP.; U.S.A.; DA. 1978; VOL. 62; NO 4; PP. 555-558; BIBL. 7 REF.Article

CHEMOTHERAPY OF RECURRENT OVARIAN CARCINOMA WITH CISDICHLORODIAMMINE PLATINUM II AND ADRIAMYCINWALLACH RC; COHEN C; BRUCKNER H et al.1980; OBSTETR. AND GYNECOL.; USA; DA. 1980; VOL. 55; NO 3; PP. 371-372; BIBL. 8 REF.Article

CISPLATIN REGIMENS AND IMPROVED PROGNOSIS OF PATIENTS WITH POORLY DIFFERENTIATED OVARIAN CANCER = LES ASSOCIATIONS A BASE DE CISPLATINUM ET L'AMELIORATION DU PRONOSTIC DES SUJETS AYANT UN CANCER DE L'OVAIRE FAIBLEMENT DIFFERENCIEBRUCKNER HW; COHEN CJ; GOLDBERG JD et al.1983; AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY; ISSN 0002-9378; USA; DA. 1983; VOL. 145; NO 6; PP. 653-658; ABS. ENG; BIBL. 14 REF.; GRAPHArticle

IMPROVED CHEMOTHERAPY FOR OVARIAN CANCER WITH CIS-DIAMMINEDICHLOROPLATINUM AND ADRIAMYCINBRUCKNER HW; COHEN CJ; GOLDBERG JD et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 9; PP. 2288-2294; BIBL. 29 REF.Article

IMPROVED THERAPY WITH CISPLATIN REGIMENS FOR PATIENTS WITH OVARIAN CARCINOMA (FIGO STAGES III AND IV) AS MEASURED BY SURGICAL END-STAGING (SECOND-LOOK OPERATION) = AMELIORATION DES RESULTATS THERAPEUTIQUES VERIFIES PAR UNE CHIRURGIE DE SECOND LOOK, POUR UNE CHIMIOTHERAPIE COMPORTANT DU CIS-PLATINE DANS LES TUMEURS DE L'OVAIRE (STADE III ET IV FIGO)COHEN CJ; GOLDBERG JD; HOLLAND JF et al.1983; AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY; ISSN 0002-9378; USA; DA. 1983; VOL. 145; NO 8; PP. 955-967; ABS. ENG; BIBL. 17 REF.; GRAPHArticle